pyrazines has been researched along with Muscular Dystrophies in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Jampel, SB; Jasper, JR; Malik, FI; Miciak, JJ; Tankersley, C; Tibbs, ME; Wagner, KR; Warsing, LC | 1 |
Azakir, BA; Di Fulvio, S; Erne, B; Sinnreich, M; Stirnimann, G | 1 |
1 trial(s) available for pyrazines and Muscular Dystrophies
Article | Year |
---|---|
Proteasome inhibitors increase missense mutated dysferlin in patients with muscular dystrophy.
Topics: Administration, Intravenous; Adult; Alleles; Boronic Acids; Bortezomib; Cell Membrane; Cells, Cultured; Dysferlin; Humans; Male; Membrane Proteins; Monocytes; Muscle Proteins; Muscular Dystrophies; Mutation, Missense; Myoblasts; Proteasome Inhibitors; Pyrazines | 2014 |
1 other study(ies) available for pyrazines and Muscular Dystrophies
Article | Year |
---|---|
Fast skeletal muscle troponin activator in the dy2J muscular dystrophy model.
Topics: Analysis of Variance; Animals; Creatine Kinase; Disease Models, Animal; Female; Imidazoles; Laminin; Longitudinal Studies; Mice; Mice, Inbred C57BL; Mice, Transgenic; Muscle Fibers, Skeletal; Muscle Strength; Muscular Dystrophies; Mutation; Physical Endurance; Pyrazines; Respiratory Physiological Phenomena; Troponin | 2013 |